News Headlines Article

FDA sends McKesson a warning over alleged tampered opioids
Modern Healthcare

The U.S. Food and Drug Administration has sent a warning letter to drug distributing giant McKesson Corp. for allegedly shipping pharmacies opioid products with pills missing or non-opioid replacements.

The agency documented several alleged incidents when the company shipped tampered opioid products, stemming from what it found during inspections of McKesson’s corporate headquarters and a distribution center.

In its warning letter, the agency cites the company for allegedly failing to sufficiently respond, quarantine and investigate shipments of oxycodone hydrochloride sent to three Rite Aid pharmacies in 2016 after McKesson had been notified about the tampering issues.